Half Year 2025 Santhera Pharmaceuticals Holding AG Analyst Briefing Transcript
Good afternoon, ladies and gentlemen. Welcome to the Santhera Pharmaceuticals' half-year results investor presentation. (Operator Instructions)
Before we begin, we would just like to submit the following poll, and if you could give that your kind attention, I'm sure the company would be most grateful.
And I would now like to hand you over to the team from Santhera Pharmaceuticals. Katherine, Shabir, good afternoon.
Good afternoon, everyone, and welcome again to the interim results for the six months ending the 30th of June 2025. Giving the presentation today is myself, Catherine Isted, the CFO, as well as our Chief Medical Officer, Dr. Shabir Hasham.
Unfortunately, our CEO, Dario Eklund cannot be with us today, as he's actually had a recent operation on his shoulder, but he will be back with us shortly. As was said in the introduction, there will be an opportunity to ask questions at the end of the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
